ADIPOQ and type 2 diabetes mellitus: Recent studies have confirmed that EFT is associated with obesity, fasting blood glucose levels, insulin resistance, and adiponectin in patients with T2DM, and an increase in EFT was observed in patients with T1DM and T2DM [18–22].